ARTICLE | Management Tracks
Roche veteran Chow becomes head of China & international at Merck KGaA
Plus: Bayer, Bluerock, Qiming, Editas and more
July 27, 2021 1:13 AM UTC
Hong Chow will join the healthcare business sector of Merck KGaA (Xetra:MRK) as head of China & international, effective Oct. 1. Chow previously served as CEO of Roche (SIX:ROG; OTCQX:RHHBY) Pharmaceuticals China for more than six years.
Bayer AG (Xetra:BAYN) named Dominik Ruettinger as head of research and early development for oncology at its pharmaceutical division, effective Oct.1. Ruettinger was most recently SVP, global head of oncology at Roche...